H. Zhou

发表

Sequential activation of heterotrimeric and monomeric G proteins mediates PLD activity in smooth muscle.

H. Zhou, J. Grider, G. Makhlouf, 2001, American journal of physiology. Gastrointestinal and liver physiology.

G(i-1)/G(i-2)-dependent signaling by single-transmembrane natriuretic peptide clearance receptor.

H. Zhou, G. Makhlouf, K. Murthy, 2000, American journal of physiology. Gastrointestinal and liver physiology.

Carboxy-substituted cinnamides: a novel series of potent, orally active LTB4 receptor antagonists.

R. Fujimoto, R. Pelletier, K. Lipson, 1999, Journal of Medicinal Chemistry.

Enhanced high-level expression of soluble 1-aminocyclopropane-1-carboxylase synthase and rapid purification by expanded-bed adsorption.

H. Zhou, N. Li, S. Huxtable, 1998, Protein expression and purification.

Renaturation of 1-aminocyclopropane-1-carboxylate synthase expressed in Escherichia coli in the form of inclusion bodies into a dimeric and catalytically active enzyme.

H. Zhou, S. Huxtable, N. Li, 1998, Protein expression and purification.

Investigation of human apoB48 metabolism using a new, integrated non‐steady‐state model of apoB48 and apoB100 kinetics

J. Borén, M. Taskinen, H. Zhou, 2019, Journal of internal medicine.

Covalent attachment of ethidium to DNA results in enhanced topoisomerase II-mediated DNA cleavage.

N. Osheroff, H. Zhou, G. Marx, 1997, Biochemistry.

2-Aminoethoxydiphenyl borate (2-APB) inhibits capacitative calcium entry independently of the function of inositol 1,4,5-trisphosphate receptors.

K. Mikoshiba, H. Zhou, K. Uchida, 2001, Receptors & channels.

Tyrosine kinase inhibitors. 15. 4-(Phenylamino)quinazoline and 4-(phenylamino)pyrido[d]pyrimidine acrylamides as irreversible inhibitors of the ATP binding site of the epidermal growth factor receptor.

W. Denny, G. Rewcastle, A. Bridges, 1999, Journal of medicinal chemistry.

Induction of metalloproteinase activity in human T-lymphocytes.

H. Zhou, E. Bernhard, P. Billings, 1993, Biochimica et biophysica acta.

Tyrosine kinase inhibitors. 10. Isomeric 4-[(3-bromophenyl)amino]pyrido[d]-pyrimidines are potent ATP binding site inhibitors of the tyrosine kinase function of the epidermal growth factor receptor.

W. Denny, G. Rewcastle, A. Bridges, 1996, Journal of medicinal chemistry.

Characterization of recombinant human CXCR4 in insect cells: role of extracellular domains and N-glycosylation in ligand binding.

H. Tai, H. Zhou, H. Zhou, 1999, Archives of biochemistry and biophysics.

Expression and functional characterization of mutant human CXCR4 in insect cells: role of cysteinyl and negatively charged residues in ligand binding.

H. Tai, H. Zhou, H Zhou, 2000, Archives of biochemistry and biophysics.

C-Terminal region of human NAD+-dependent 15-hydroxyprostaglandin dehydrogenase is involved in the interaction with prostaglandin substrates.

H. Tai, H. Zhou, F. Yan, 2001, European journal of biochemistry.

Role of proline, glycerol, and heparin as protein folding aids during refolding of rabbit muscle creatine kinase.

H. Zhou, H Zhou, F Meng, 2001, The international journal of biochemistry & cell biology.

Tyrosine kinase inhibitors. 8. An unusually steep structure-activity relationship for analogues of 4-(3-bromoanilino)-6,7-dimethoxyquinazoline (PD 153035), a potent inhibitor of the epidermal growth factor receptor.

W. Denny, G. Rewcastle, A. Bridges, 1996, Journal of medicinal chemistry.

Nuclear magnetic resonance assignments and global fold of a CheY-binding domain in CheA, the chemotaxis-specific kinase of Escherichia coli.

L. Kay, F. Dahlquist, T. B. Morrison, 1995, Biochemistry.

Enantioselective inhibition of the epidermal growth factor receptor tyrosine kinase by 4-(alpha-phenethylamino)quinazolines.

A. Bridges, D. W. Fry, H. Zhou, 1995, Bioorganic & medicinal chemistry.

Investigation of human apoB48 metabolism using a new, integrated non‐steady‐state model of apoB48 and apoB100 kinetics

J. Borén, M. Taskinen, C. Packard, 2019, Journal of internal medicine.

Phosphorylation and desensitization of the human thromboxane receptor-alpha by G protein-coupled receptor kinases.

H. Tai, H. Zhou, F. Yan, 2001, The Journal of pharmacology and experimental therapeutics.

Phosphotransfer site of the chemotaxis-specific protein kinase CheA as revealed by NMR.

F. Dahlquist, F W Dahlquist, H Zhou, 1997, Biochemistry.

Phosphotransfer and CheY-binding domains of the histidine autokinase CheA are joined by a flexible linker.

M. Simon, F. Dahlquist, H. Zhou, 1996, Biochemistry.

On the human CYP2C9*13 variant activity reduction: a molecular dynamics simulation and docking study.

H. Zhou, Qingchuan Zheng, L. Cai, 2006, Biochimie.

Catalytic activities of human cytochrome P450 2C9*1, 2C9*3 and 2C9*13

H. Zhou, D. Zhong, Y. Wang, 2005, Xenobiotica; the fate of foreign compounds in biological systems.

NMR studies of the phosphotransfer domain of the histidine kinase CheA from Escherichia coli: assignments, secondary structure, general fold, and backbone dynamics.

M. Simon, F. Dahlquist, R. Swanson, 1995, Biochemistry.

Tyrosine kinase inhibitors. 16. 6,5,6-tricyclic benzothieno[3, 2-d]pyrimidines and pyrimido[5,4-b-] and -[4,5-b]ĭndoles as potent inhibitors of the epidermal growth factor receptor tyrosine kinase.

A. Bridges, D. W. Fry, H. D. Showalter, 1999, Journal of medicinal chemistry.

Excited-state electronic asymmetry of the special pair in photosynthetic reaction center mutants: absorption and Stark spectroscopy.

S. Boxer, H. Zhou, L. Moore, 1999, Biochemistry.

The multiple roles of conserved arginine 286 of 1-aminocyclopropane-1-carboxylate synthase. Coenzyme binding, substrate binding, and beyond.

H. Zhou, S. Yang, P. Xu, 1999, Plant physiology.

INASE- AND RAPSYN-INDEPENDENT ACTIVITIES OF THE MUSCLE- PECIFIC KINASE (MuSK)

H. Zhou, .. A. Bromann, 2004 .

Regulatory role of arginine-specific mono(ADP-ribosyl)transferase in muscle cells.

S. W. Sernett, H. Zhou, D. Graves, 1997, Advances in experimental medicine and biology.

Tyrosine kinase inhibitors. 5. Synthesis and structure-activity relationships for 4-[(phenylmethyl)amino]- and 4-(phenylamino)quinazolines as potent adenosine 5'-triphosphate binding site inhibitors of the tyrosine kinase domain of the epidermal growth factor receptor.

W. Denny, G. Rewcastle, A. Bridges, 1995, Journal of medicinal chemistry.

Biochemical and antiproliferative properties of 4-[ar(alk)ylamino]pyridopyrimidines, a new chemical class of potent and specific epidermal growth factor receptor tyrosine kinase inhibitor.

W. Denny, G. Rewcastle, A. Bridges, 1997, Biochemical pharmacology.

Identification of dipeptidyl nitriles as potent and selective inhibitors of cathepsin B through structure-based drug design.

R. Bohacek, H. Zhou, K. Clark, 2001, Journal of medicinal chemistry.

Caspase-mediated cleavage of the TIAM1 guanine nucleotide exchange factor during apoptosis.

M. Chou, H. Zhou, P. Juo, 2001, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

Resonance Raman spectroscopic characterization of alpha-hydroxyheme and verdoheme complexes of heme oxygenase.

S. Takahashi, D. Rousseau, M. Ikeda-Saito, 1997, Biochemistry.

Molecular oxygen oxidizes the porphyrin ring of the ferric alpha-hydroxyheme in heme oxygenase in the absence of reducing equivalent.

S. Takahashi, H. Zhou, H. Fujii, 1999, Biochimica et biophysica acta.